Search results
When Tesla shares rise — these 7 stocks have tended to rise too, according to recent history
CNBC· 7 hours agoThe U.S.-listed stocks are cybersecurity and networking gear maker Juniper Networks , digital...
DOJ Files False Claims Act Complaint Against Regeneron, Alleging Fraudulent Eylea Drug Pricing | JD...
JD Supra· 2 days agoAs we previously reported, the U.S. Department of Justice (“DOJ”) filed a lawsuit under the Anti-Kickback Statute against Regeneron Pharmaceuticals in the District of Massachusetts ...
DOJ Files Second Qui Tam Lawsuit Against Regeneron Pharmaceuticals
The National Law Review· 7 days agoThe United States announced that it has intervened in a False Claims Act case against New York-based Regeneron Pharmaceuticals Inc. (Regeneron). The suit ...
2 Small-Cap Growth Stocks With Room to Run
Motley Fool via Yahoo Finance· 1 hour agoThe therapy, known as Axpaxli, could carve out a profitable niche in a market dominated by biotech giants Regeneron Pharmaceuticals and Roche, thanks to...
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Zacks via Yahoo Finance· 6 days agoIt was a busy week in the biotech sector with lots of important regulatory and pipeline updates....
JD Supra: Updates on Aflibercept BPCIA Litigation
JD Supra· 5 days agoAs we previously reported, on January 11, 2024, Regeneron Pharmaceuticals, Inc. (“Regeneron”) filed a motion seeking to establish a multi-district litigation ...
REGENERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Regeneron Pharmaceuticals, Inc. on...
Morningstar· 7 days agoNEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Regeneron< ...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals,...
Morningstar· 6 days agoNEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Regeneron Pharmaceuticals, Inc. (“Regeneron ...
Federal Circuit Dismisses Appeals in Regeneron v. Mylan (Aflibercept) BPCIA Litigation | JD Supra
JD Supra· 2 days agoAs we previously reported, trial in Regeneron Pharmaceutical, Inc.’s BPCIA case against Mylan Pharmaceuticals Inc. and Biocon Biologics, Inc. (collectively, “the Biocon Defendants ...
Roche eyes return to growth after Q1 hit by forex, loss of COVID sales
Reuters· 7 hours ago, opens new tab confirmed ambitions to return to sales growth this year on a continued boost from...
